Comparing neuroprotective effects of CDNF-expressing bone marrow derived mesenchymal stem cells via differing routes of administration utilizing an in vivo model of Parkinson’s disease

[1]  Xiaomin Wang,et al.  AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model , 2013, Experimental Neurology.

[2]  B. Hoffer,et al.  CDNF Protects the Nigrostriatal Dopamine System and Promotes Recovery after MPTP Treatment in Mice , 2012, Cell transplantation.

[3]  N. Xiong,et al.  VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson’s disease , 2011, Gene Therapy.

[4]  M. Saarma,et al.  Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease , 2011, Experimental Neurology.

[5]  Cheuk-Kwan Sun,et al.  Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats , 2010, Journal of Translational Medicine.

[6]  M. Saarma,et al.  Novel CDNF/MANF family of neurotrophic factors , 2010, Developmental neurobiology.

[7]  Wenbo Yu,et al.  Intrastriatal Transplantation of GDNF-engineered BMSCs and its neuroprotection in Lactacystin-induced Parkinsonian Rat Model , 2010, Neurochemical Research.

[8]  M. Saarma,et al.  Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo , 2007, Nature.

[9]  Yu-hong Zhang,et al.  Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson’s disease , 2007, Brain Research.

[10]  Jianjun Wu,et al.  Overexpression of lentivirus-mediated glial cell line-derived neurotrophic factor in bone marrow stromal cells and its neuroprotection for the PC12 cells damaged by lactacystin , 2007, Neuroscience bulletin.

[11]  Mark Stacy,et al.  Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease , 2006, Annals of neurology.

[12]  J. Mallet,et al.  Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease , 2006, Neurobiology of Disease.

[13]  M. Hoshino,et al.  Potential of bone marrow stromal cells in applications for neuro-degenerative, neuro-traumatic and muscle degenerative diseases. , 2005, Current neuropharmacology.

[14]  Xiaohong Sun,et al.  Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease. , 2005, Brain research. Brain research protocols.

[15]  Mari Dezawa,et al.  Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. , 2004, The Journal of clinical investigation.

[16]  B. Crain,et al.  Transplanted bone marrow generates new neurons in human brains , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  T. Itakura,et al.  Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson’s disease , 2002, Brain Research.

[18]  Kun-Woo Park,et al.  Protection of nigral neurons by GDNF-engineered marrow cell transplantation , 2001, Neuroscience Research.

[19]  H. Blau,et al.  From marrow to brain: expression of neuronal phenotypes in adult mice. , 2000, Science.

[20]  R. Jindal,et al.  Stable transfection of rat preporinsulin II gene into rat hematopoietic stem cells via recombinant adeno-associated virus. , 1999, Life sciences.

[21]  N. Munshi,et al.  Bone marrow stromal cells as a vehicle for gene transfer , 1999, Gene Therapy.

[22]  D. Dawson,et al.  Targeting of marrow-derived astrocytes to the ischemic brain. , 1999, Neuroreport.

[23]  T. Sakata,et al.  [Changes in meal patterns and endogenous chemical determinants related to food intake following intra-ventricle III infusion of mazindol]. , 1984, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[24]  Y. Oomura,et al.  Feeding suppression induced by intra-ventricle III infusion of 1,5-anhydroglucitol , 1983, Physiology & Behavior.

[25]  I. Date,et al.  Single administration of GDNF into the striatum induced protection and repair of the nigrostriatal dopaminergic system in the intrastriatal 6-hydroxydopamine injection model of hemiparkinsonism. , 2000, Restorative Neurology and Neuroscience.